Need a Reliable Peptide Supplier? Click HERE!!!SponsoredVisit ↗
Tesofensine and BAC Water Mix

Tesofensine Reconstitution Calculator

Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.

What amount do you need?

Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.

Work the dose out from body weight

Syringe size:
Possible vial strengths:
Best Match Good Match Usable Harder to Measure

Example Tesofensine Titration Schedule

ParameterDetails
Phase 3 doses0.25 / 0.5 mg oral once daily
Dropped dose1.0 mg (heart rate/BP)
Duration24 weeks (Phase 2/3)
Half-life~9 days (~220 h)

Not FDA-approved (no cardiovascular outcomes trial exists; approved nowhere for prescription). The 0.125 mg start and 1 mg maximum in listed tables do not match any completed trial.

Possible vial strengths: 500mcg

What Is It?

Tesofensine

Monoamine reuptake inhibitor studied for weight research.

Bacteriostatic Water

Sterile water containing a bacteriostatic preservative, commonly used when preparing multi-use research vials.

How To Mix Tesofensine

1
Clean

Use alcohol swabs to clean the tops of both vials.

2
Draw BAC Water

Draw the selected amount of bacteriostatic water.

3
Inject Slowly

Add the liquid slowly down the side of the vial.

4
Swirl Gently

Do not shake. Swirl gently until dissolved.

5
Store Properly

Store as directed and protect from heat and light.

Best Practices & Common Mistakes

Best Practices

  • Use sterile technique.
  • Protect from light and heat.
  • Store refrigerated when appropriate.
  • Use clean syringe-unit math before measuring.

Common Mistakes

  • Confusing milligrams with milliliters.
  • Choosing an option with awkward decimal units.
  • Using too little liquid for very small measurements.
  • Shaking the vial aggressively.

Tesofensine Storage & Handling

Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.

Frequently Asked Questions

Tesofensine is often listed near peptides because people compare it with weight-loss research compounds, but chemically it is not a peptide. It is a small-molecule serotonin, norepinephrine, and dopamine reuptake inhibitor, so a reconstitution calculator should not treat it like a lyophilized injectable peptide.
Tesofensine acts mainly through central monoamine signaling, while semaglutide and tirzepatide act through incretin hormone receptors. That makes tesofensine more similar to a CNS appetite-modulating compound than to a GLP-1 peptide or dual incretin injection.
Searches for 500 mcg usually reflect how tesofensine is discussed in capsules, tablets, or research listings, not a universal instruction. A calculator page can explain unit conversion clearly: 500 mcg equals 0.5 mg, but that conversion alone does not tell anyone when, how, or whether to use it.
Because tesofensine affects dopamine, norepinephrine, and serotonin signaling, side-effect and withdrawal searches should be taken seriously. Common discussion points include insomnia, dry mouth, mood changes, heart-rate changes, and stimulant-like effects, so this topic should be framed as safety context rather than casual supplement talk.
For research math only, concentration equals compound amount divided by final solution volume. For example, if 5 mg of tesofensine reference material were dissolved to a final volume of 20 mL, the concentration would be 0.25 mg/mL; a 500 mcg research aliquot would equal 2.00 mL. This is lab concentration math, not a dosing, injection, or administration guide.
Practical takeaway: If your goal involves weight management, metabolic health, recovery, physical performance, cognitive function, appearance, or general well-being, discuss it with a licensed healthcare professional. They can help you evaluate approved, evidence-based options rather than relying on an unapproved or investigational compound. This calculator is intended only for transparent research-reference calculations and does not determine an appropriate amount, recommend use, or replace professional medical guidance.

About the author

Maria Hrabina is a pharmacist and scientific reviewer with a strong interest in peptide science, pharmacology, and emerging therapeutic compounds.

Her work focuses on understanding how peptide-based compounds interact with biological signaling pathways and how they are being investigated across areas such as metabolic health, dermatology, recovery, regenerative research, and pharmaceutical development.

Maria follows research on a broad range of peptides, from compounds used in approved medicines to experimental molecules still being evaluated in laboratory, preclinical, and clinical studies.

Her approach combines scientific curiosity with critical evaluation of evidence. She believes promising mechanisms and early research deserve attention, but should not be presented as established clinical benefits until they are supported by adequate human data.

Her areas of focus include scientific literature review, mechanisms of action, pharmacology, pharmacokinetics, safety, pharmaceutical formulation, and the overall quality of evidence behind peptide-based compounds.

She is particularly interested in the process of translating an experimental molecule into a reliable pharmaceutical product — including compound characterization, purity, stability, formulation, dose selection, safety assessment, and controlled clinical trials.

Maria believes peptide science has significant long-term potential, but that its progress depends on rigorous research, high manufacturing standards, transparent safety data, and responsible scientific communication.

Through her writing, she aims to help readers understand both sides of peptide research: what makes these compounds scientifically promising and what questions remain before their potential can be considered clinically established.

Areas of interest: Peptide Science · Therapeutic Peptides · Peptide Pharmacology · Metabolic Peptides · Cosmetic Peptides · Drug Development · Pharmacokinetics · Drug Safety · Pharmaceutical Formulation · Emerging Therapies · Evidence-Based Medicine

Important: This tool is for informational and research-reference purposes only. Not intended for human or veterinary use.
← All peptides